17 Nov 2026Tue,

Rapid Healthcares
Diabetes

WHO Unveils Groundbreaking Guidelines for Adults with Type 1 Diabetes

The WHO has released comprehensive guidelines for managing type 1 diabetes in adults, ensuring better care and access to insulin worldwide.

New Guidelines Released for Type 1 Diabetes

On November 14, 2026, the World Health Organization (WHO) celebrated World Diabetes Day by launching its inaugural guidelines aimed at adults living with type 1 diabetes. These recommendations are particularly significant for healthcare systems facing various challenges, including limited resources and crisis situations.

The Growing Prevalence of Type 1 Diabetes

Recent statistics reveal that around 9.5 million individuals worldwide were diagnosed with type 1 diabetes by 2025, with an additional 500,000 cases reported that same year. While type 1 diabetes is often thought to predominantly affect children, its impact on adults is becoming increasingly pronounced.

This chronic condition occurs when the body fails to produce sufficient insulin, making daily insulin administration vital for survival. Despite advancements in medicine, many patients struggle to access the insulin and healthcare they require.

Addressing Accessibility Challenges

Dr. Søren Brostrøm, serving as the WHO Director of Noncommunicable Diseases and Mental Health, pointed out that the availability of affordable, high-quality insulin remains a critical hurdle for those with type 1 diabetes. The newly issued guidelines aim to support governments in delivering effective care, especially in regions where healthcare resources are stretched thin or services have been interrupted.

The WHO recommends that adults with type 1 diabetes use multiple daily insulin injections, adjusting their doses based on blood glucose measurements. Human insulin, a synthetic version of the hormone produced by the pancreas, is regarded as a practical treatment. Alternative formulations may also be employed when deemed necessary.

Monitoring Blood Glucose Levels

Another vital aspect of managing type 1 diabetes is regular blood glucose monitoring. Healthcare facilities can evaluate patients' average blood sugar levels through routine blood tests conducted over a few months. For home management, patients can opt for finger-prick tests or utilize continuous glucose monitoring systems that feature tiny sensors worn on the skin.

In settings where blood glucose testing is not an option, the WHO suggests that urine glucose testing could serve as a backup method.

Aiming for Universal Access by 2030

The guidelines are aligned with the WHO's aspiration to ensure that every individual living with type 1 diabetes has access to affordable insulin treatment and effective blood glucose monitoring by the year 2030. To facilitate the implementation of these guidelines, the WHO plans to supply valuable resources and instruments for tracking progress. Furthermore, national authorities are encouraged to engage individuals with type 1 diabetes in the development, execution, and evaluation of diabetes programs.

This year, World Diabetes Day is focused on the theme "Early action on diabetes," underscoring the urgency of prompt diagnosis and treatment options. Left unchecked, diabetes can lead to severe health complications such as vision impairment, kidney failure, cardiovascular issues, strokes, and amputations.

Since 1990, the prevalence of diabetes has skyrocketed, increasing by more than four times. As of 2022, an estimated 830 million individuals globally were living with diabetes, the majority of whom have type 2 diabetes. Alarmingly, WHO data reveals that over 40% of those with diabetes remain unaware of their condition, leading to increased health risks.

In related discussions, endocrinologist Aidana Kabiyeva recently highlighted the unique challenges of managing type 1 diabetes in children, recognizing the need for comprehensive care across all ages.

More from the newsroom

All stories